Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Tackenberg

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of Clinical Immunology|April 29, 2010
Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathyBjörn Tackenberg, Falk Nimmerjahn, Jan D Lünemann
BMC Neurology|May 26, 2023
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathyJuliane Klehmet, Björn Tackenberg, Judith Haas, et al.
Frontiers in Neurology|September 26, 2025
Federated learning for lesion segmentation in multiple sclerosis: a real-world multi-center feasibility studySarah Hindawi, Bartlomiej Szubstarski, Eric Boernert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2015
Deregulated Fcγ receptor expression in patients with CIDPIsaak Quast, Flavio Cueni, Falk Nimmerjahn, et al.
Annals of Clinical and Translational Neurology|September 21, 2016
Terminal complement activation is increased and associated with disease severity in CIDPIsaak Quast, Christian W Keller, Falk Hiepe, et al.
Plos One|June 26, 2014
MK2 and Fas receptor contribute to the severity of CNS demyelinationSilvia M Tietz, Regina Hofmann, Tobias Thomas, et al.
Annals of Neurology|September 10, 2011
Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravisKristina Kakalacheva, Michael A Maurer, Björn Tackenberg, et al.
The Journal of Experimental Medicine|July 30, 2008
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2Jan D Lünemann, Ilijas Jelcić, Susanne Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathyBjörn Tackenberg, Ilijas Jelcic, Anne Baerenwaldt, et al.
European Journal of Immunology|February 27, 2007
Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravisBjörn Tackenberg, Jens Kruth, Johanna E Bartholomaeus, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of Clinical Immunology|April 29, 2010
Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathyBjörn Tackenberg, Falk Nimmerjahn, Jan D Lünemann
BMC Neurology|May 26, 2023
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathyJuliane Klehmet, Björn Tackenberg, Judith Haas, et al.
Frontiers in Neurology|September 26, 2025
Federated learning for lesion segmentation in multiple sclerosis: a real-world multi-center feasibility studySarah Hindawi, Bartlomiej Szubstarski, Eric Boernert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2015
Deregulated Fcγ receptor expression in patients with CIDPIsaak Quast, Flavio Cueni, Falk Nimmerjahn, et al.
Annals of Clinical and Translational Neurology|September 21, 2016
Terminal complement activation is increased and associated with disease severity in CIDPIsaak Quast, Christian W Keller, Falk Hiepe, et al.
Plos One|June 26, 2014
MK2 and Fas receptor contribute to the severity of CNS demyelinationSilvia M Tietz, Regina Hofmann, Tobias Thomas, et al.
Annals of Neurology|September 10, 2011
Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravisKristina Kakalacheva, Michael A Maurer, Björn Tackenberg, et al.
The Journal of Experimental Medicine|July 30, 2008
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2Jan D Lünemann, Ilijas Jelcić, Susanne Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathyBjörn Tackenberg, Ilijas Jelcic, Anne Baerenwaldt, et al.
European Journal of Immunology|February 27, 2007
Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravisBjörn Tackenberg, Jens Kruth, Johanna E Bartholomaeus, et al.
Pageof 9